S&P 500
(0.27%) 5 075.53 points
Dow Jones
(0.59%) 37 958 points
Nasdaq
(0.41%) 15 950 points
Oil
(-0.19%) $85.25
Gas
(2.07%) $1.726
Gold
(0.76%) $2 401.20
Silver
(-1.47%) $28.30
Platinum
(-0.83%) $972.90
USD/EUR
(-0.04%) $0.941
USD/NOK
(0.34%) $10.97
USD/GBP
(0.00%) $0.803
USD/RUB
(-0.38%) $93.15

Realtime updates for Torii Pharmaceutical Co., [4551.T]

Exchange: JPX Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Last Updated16 Apr 2024 @ 02:15

-2.70% ¥ 3 790.00

Live Chart Being Loaded With Signals

Commentary (16 Apr 2024 @ 02:15):

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients...

Stats
Today's Volume 26 500.00
Average Volume 29 888.00
Market Cap 106.52B
EPS ¥0 ( 2024-02-08 )
Next earnings date ( ¥0 ) 2024-04-25
Last Dividend ¥50.00 ( 2023-06-29 )
Next Dividend ¥0 ( N/A )
P/E 25.86
ATR14 ¥5.70 (0.15%)

Volume Correlation

Long: 0.24 (neutral)
Short: -0.47 (neutral)
Signal:(41.32) Neutral

Torii Pharmaceutical Co., Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Torii Pharmaceutical Co., Correlation - Currency/Commodity

The country flag 0.77
( moderate )
The country flag 0.74
( moderate )
The country flag 0.63
( weak )
The country flag 0.86
( strong )
The country flag 0.68
( moderate )
The country flag -0.83
( strong negative )

Torii Pharmaceutical Co., Financials

Annual 2023
Revenue: ¥54.64B
Gross Profit: ¥24.57B (44.97 %)
EPS: ¥146.57
Q4 2023
Revenue: ¥15.51B
Gross Profit: ¥6.76B (43.58 %)
EPS: ¥62.30
Q3 2023
Revenue: ¥13.43B
Gross Profit: ¥6.11B (45.45 %)
EPS: ¥45.61
Q2 2023
Revenue: ¥13.89B
Gross Profit: ¥6.41B (46.13 %)
EPS: ¥48.89

Financial Reports:

No articles found.

Torii Pharmaceutical Co., Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥0
(N/A)
¥76.00
(N/A)
¥0
(N/A)
¥50.00
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

Torii Pharmaceutical Co., Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 8.90 - good (89.04%) | Divividend Growth Potential Score: 4.41 - Stable (11.75%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend ¥2.00 2001-03-27
Last Dividend ¥50.00 2023-06-29
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 47 --
Total Paid Out ¥907.00 --
Avg. Dividend % Per Year 0.00% --
Score 3.47 --
Div. Sustainability Score 8.90
Div.Growth Potential Score 4.41
Div. Directional Score 6.66 --
Next Divdend (Est)
(2024-09-25)
¥0 Estimate 3.76 %
Dividend Stability
0.30 Poor
Dividend Score
3.47
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
8091.T Ex Dividend Junior 2023-09-28 Annually 0 0.00%
7420.T Ex Dividend Knight 2023-11-29 Semi-Annually 0 0.00%
6640.T Ex Dividend Junior 2023-12-28 Semi-Annually 0 0.00%
5970.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
4665.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
3904.T Ex Dividend Junior 2023-12-28 Sporadic 0 0.00%
3141.T Ex Dividend Knight 2024-02-28 Semi-Annually 0 0.00%
2060.T Ex Dividend Junior 2023-09-28 Annually 0 0.00%
9706.T Ex Dividend Junior 2023-09-28 Annually 0 0.00%
8715.T Ex Dividend Knight 2024-03-28 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.07541.5008.4910.00[0 - 0.5]
returnOnAssetsTTM0.03091.2008.9710.00[0 - 0.3]
returnOnEquityTTM0.03471.500-0.725-1.088[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM7.050.80010.008.00[1 - 3]
quickRatioTTM6.090.80010.008.00[0.8 - 2.5]
cashRatioTTM2.771.50010.0010.00[0.2 - 2]
debtRatioTTM0.00183-1.5009.97-10.00[0 - 0.6]
interestCoverageTTM-152.611.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM32.662.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM32.662.0010.0010.00[0 - 20]
debtEquityRatioTTM0.00203-1.5009.99-10.00[0 - 2.5]
grossProfitMarginTTM0.4541.0005.775.77[0.2 - 0.8]
operatingProfitMarginTTM0.09221.000-0.157-0.157[0.1 - 0.6]
cashFlowToDebtRatioTTM3.761.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.4090.800-0.603-0.483[0.5 - 2]
Total Score8.90

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM27.031.0007.370[1 - 100]
returnOnEquityTTM0.03472.50-0.466-1.088[0.1 - 1.5]
freeCashFlowPerShareTTM32.662.0010.0010.00[0 - 30]
dividendYielPercentageTTM3.031.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM32.662.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.5901.5009.400[0.5 - 2]
operatingCashFlowSalesRatioTTM0.01681.000-2.080[0.1 - 0.5]
Total Score4.41

Torii Pharmaceutical Co.,

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators